FDA Issues Safety Alert for Impella Heart Pumps Following Fatality

The U.S. Food and Drug Administration has released a new warning concerning specific Impella heart pump models. This advisory follows a patient death and highlights potential design specification issues that could lead to critical malfunctions. These malfunctions, such as low purge pressure events, can interrupt life-sustaining support and carry a risk of death if not addressed promptly.